A cost‐effective approach to factor assay calibration using a truncated live calibration curve
- 17 August 2019
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 41 (5) , 679-683
Abstract
Introduction: The measurements of clotting factor activities are usually performed using a one‐stage clotting assay (OSA) or chromogenic substrate assay (CSA). Advances in automated coagulation analysers have led to the utilization of stored calibration curves. There are sometimes substantial intervals between test calibration and analysis of samples. Variability in results can be influenced by calibrant and methodology. Several guidelines recommend calibration and patient samples be performed together in parallel; this incurs costs, but reliance on a stored calibration curve may lead to inaccuracy of results over time.Methods: We evaluated inclusion of a live truncated (3 point) calibration curve using calibrator plasma alongside test samples and compared results calculated against the stored calibration curves and live truncated calibration to assess the impact on precision and accuracy. The feasibility of this was tested on two hospital sites in the UK; OSA and CSA were performed on Sysmex CS5100 using Actin FS, SynthASil, Innovin, Biophen chromogenic VIII and Rossix chromogenic IX.Results: Results of two batches of IQC were compared for FII, FV, FVII, FX, FIX:C, FXI, FXII and OSA FVIII (FVIII:C1) and CSA FVIII:C (FVIII:CR) and FXI:C. By utilizing a live truncated calibration, precision improved with the most striking examples: FXII %CV 23.1% to 3.1% (site A) FXI 7.3% to 2.4% (site B). The improvement in other clotting factors was more modest.Conclusion: To the best of our knowledge, this is the first study that demonstrates that the use of a live truncated calibration curve will improve precision and accuracy.Keywords
This publication has 7 references indexed in Scilit:
- Advantages, disadvantages and optimization of one‐stage and chromogenic factor activity assays in haemophilia A and BInternational Journal of Laboratory Hematology, 2018
- Current laboratory practices in the diagnosis and management of haemophilia: a global assessmentHaemophilia, 2015
- Assay of Factor VIII and Other Clotting Factors2013
- Guidelines on the laboratory aspects of assays used in haemostasis and thrombosisInternational Journal of Laboratory Hematology, 2012
- Measurement of factor VIII activity using one‐stage clotting assay: a calibration curve has not to be systematically included in each runHaemophilia, 2010
- Emerging Technologies and Quality Assurance: The United Kingdom National External Quality Assessment Scheme PerspectiveSeminars in Thrombosis and Hemostasis, 2007
- The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' OrganisationHaemophilia, 2004